New 'Off-the-Shelf' T Cell Therapy Developed for Liver Cancer

Researchers have developed a non-gene-editing 'off-the-shelf' T cell therapy targeting liver cancer, aiming to address scalability issues of traditional therapies. This innovative approach engineers cells effective against HBV-related liver cancer, demonstrating promising results in lab tests by selectively eliminating cancer cells while minimizing harm to healthy tissue. This could expand access to advanced cancer treatments.